Spike S1 (C-Term) Antigen (S1-CTD) for SARS-Cov (2003) Recombinant Protein

NP (CTD) is the nucleoprotein C-terminal domain of the Coronavirus nucleocapsid (N). This recombinant antigen has been prepared by expressing aa 212 to 394 from de nucleoprotein of SARS-CoV. Coronavirus nucleocapsid (N) protein is a highly phosphorylated protein which not only is responsable for construction of the ribonucleoprotein complex by interacting with the viral genome and regulating the synthesis of viral RNA and protein, but also serves as a potent immunogen that induces humoral and cellular immunity. The nucleoprotein is one of the major antigens of the SARS-CoV and there are abundant antigenic sites predicted in this protein. Compared with other viral structural proteins, the low variation rate of the N protein with regards to its size suggests its importance to the survival of the virus.

Small volumes of Spike S1 (C-term) antigen (S1-CTD) for SARS-CoV (2003) recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS505108 is a recombinant protein targeting Spike S1 (C-term) antigen (S1-CTD) for SARS-CoV (2003). Also known as Recombinant Spike S1 (C-term) antigen (S1-CTD) for SARS-CoV (2003).